Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a government operating status notice and updated version to v3.2.0; removed a previous specific disease term and downgraded to v3.1.0. The update emphasizes current operating status and versioning over the deleted term.SummaryDifference5%
- Check23 days agoChange Detected- The page now shows Revision: v3.1.0 (new). - The previous Revision: v3.0.2 was removed (updated version).SummaryDifference0.1%
- Check37 days agoChange DetectedPage revised from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.3%
- Check52 days agoChange DetectedThe web page has been updated to include new facility and publication information, specifically related to various types of leukemia and lymphoma, while removing some previous location and disease terms.SummaryDifference10%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference1%
Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.